{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:06:35Z","timestamp":1791939995127,"version":"4.3.4"},"reference-count":28,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi260117-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>\n                      Prescription drug promotion by social media influencers (hereinafter\n                      <jats:italic toggle=\"yes\">influencers<\/jats:italic>\n                      ) is a growing phenomenon that raises concerns about misleading advice, insufficient regulatory oversight, and ethically problematic marketing practices. Understanding the scope and risks of influencers\u2019 promotional activities is essential to protect public health.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260117-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To systematically review existing research on influencer prescription drug promotion, with a focus on identifying recurring themes, regulatory gaps, and opportunities for intervention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260117-6\">\n                    <jats:title>Evidence Review<\/jats:title>\n                    <jats:p>This systematic scoping review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses reporting guideline. The search strategy was developed with a health sciences librarian and preregistered on Open Science Framework. English-language articles from peer-reviewed journals were retrieved from the Medline, Communication &amp;amp;amp; Mass Media Complete, CINAHL Complete, PsycInfo, Web of Science, Business Source Complete, Scopus, and Cochrane Library databases, covering research conducted in diverse online and health care contexts worldwide from 2004 to 2024. Searches used key terms related to influencers, social media, and prescription drugs, completed on March 13, 2024. Included studies underwent thematic analysis. The primary outcomes included concerns related to accuracy (misinformation), transparency (disclosure practices), and persuasiveness (personal and parasocial narratives) of prescription drug promotion by influencers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260117-7\">\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>Twelve articles met inclusion criteria (8 empirical and 4 theoretical), addressing topics such as contraceptive advertising, performance-enhancing drugs, and broader pharmaceutical promotion. Methods included content analyses, interviews, and experiments. Three recurring themes emerged: (1) misinformation stemming from influencers\u2019 limited expertise in the context of audiences\u2019 low health literacy; (2) weak regulatory oversight and inconsistent disclosure practices; and (3) parasocial narratives that blur distinctions between personal testimony and paid promotion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260117-8\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>This systematic scoping review study of prescription drug promotion by influencers found that such promotion carried risks of inaccurate or misleading advice, often amplified through personal and emotionally resonant narratives in an environment with limited oversight and enforcement. Despite the small and fragmented evidence base, these findings highlight the urgent need for updated regulatory guidance, standardized and enforceable disclosure requirements, stronger platform accountability, and targeted digital literacy initiatives. Policymakers and researchers should act proactively to safeguard public health.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.2738","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T15:30:21Z","timestamp":1774279821000},"page":"e262738","source":"Crossref","is-referenced-by-count":10,"title":["Prescription Drug Promotion by Social Media Influencers"],"prefix":"10.1001","volume":"9","author":[{"given":"Sascha","family":"Gell","sequence":"first","affiliation":[{"name":"Center for Social and Health Innovation, MCI Management Center Innsbruck, Innsbruck, Austria"},{"name":"Department of Communication, University of Vienna, Vienna, Austria"},{"name":"Lisa Schwartz Foundation for Truth in Medicine, Norwich, Vermont"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sneha","family":"Dave","sequence":"additional","affiliation":[{"name":"Lisa Schwartz Foundation for Truth in Medicine, Norwich, Vermont"},{"name":"Generation Patient, Indianapolis, Indiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Willis","sequence":"additional","affiliation":[{"name":"Lisa Schwartz Foundation for Truth in Medicine, Norwich, Vermont"},{"name":"Department of Advertising, Public Relations and Media Design, University of Colorado Boulder, Boulder"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaina J.","family":"Vitale","sequence":"additional","affiliation":[{"name":"Lisa Schwartz Foundation for Truth in Medicine, Norwich, Vermont"},{"name":"Dartmouth Biomedical & Health Sciences Libraries, Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Woloshin","sequence":"additional","affiliation":[{"name":"Lisa Schwartz Foundation for Truth in Medicine, Norwich, Vermont"},{"name":"The Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth College, Hanover, New Hampshire"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffael","family":"Heiss","sequence":"additional","affiliation":[{"name":"Center for Social and Health Innovation, MCI Management Center Innsbruck, Innsbruck, Austria"},{"name":"Lisa Schwartz Foundation for Truth in Medicine, Norwich, Vermont"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"zoi260117r1","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2023.116387","article-title":"Social media influencers and adolescents\u2019 health: a scoping review of the research field.","volume":"340","author":"Engel","year":"2024","journal-title":"Soc Sci Med"},{"key":"zoi260117r2","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2023.116472","article-title":"The impact of social media influencers on health outcomes: systematic review.","volume":"340","author":"Powell","year":"2024","journal-title":"Soc Sci Med"},{"issue":"3","key":"zoi260117r3","doi-asserted-by":"publisher","DOI":"10.2196\/29422","article-title":"Patient influencers: the next frontier in direct-to-consumer pharmaceutical marketing.","volume":"24","author":"Willis","year":"2022","journal-title":"J Med Internet Res"},{"issue":"6","key":"zoi260117r4","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1080\/0144929X.2022.2045358","article-title":"Patients as health influencers: motivations and consequences of following cancer patients on Instagram.","volume":"42","author":"Heiss","year":"2023","journal-title":"Behav Inf Technol"},{"issue":"9","key":"zoi260117r7","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1001\/jamainternmed.2024.0340","article-title":"I read health information online\u2014can I trust it?","volume":"184","author":"Johnson-Arbor","year":"2024","journal-title":"JAMA Intern Med"},{"issue":"24","key":"zoi260117r8","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1001\/jama.2024.7832","article-title":"Industry payments to physicians endorsing drugs and devices on a social media platform.","volume":"331","author":"Persaud","year":"2024","journal-title":"JAMA"},{"key":"zoi260117r9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l2336","article-title":"Key opinion leaders supercharged by the internet: paid doctor and patient influencers on social media.","author":"Thomas","year":"2019","journal-title":"BMJ"},{"issue":"2","key":"zoi260117r11","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.61940","article-title":"Social media posts about medical tests with potential for overdiagnosis.","volume":"8","author":"Nickel","year":"2025","journal-title":"JAMA Netw Open"},{"key":"zoi260117r12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2025-086061","article-title":"Responding to public health challenges of medical advice from social media influencers.","volume":"391","author":"Heiss","year":"2025","journal-title":"BMJ"},{"issue":"2","key":"zoi260117r13","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.amepre.2019.03.009","article-title":"Misinformation as a misunderstood challenge to public health.","volume":"57","author":"Southwell","year":"2019","journal-title":"Am J Prev Med"},{"issue":"2","key":"zoi260117r15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology.","volume":"3","author":"Braun","year":"2006","journal-title":"Qual Res Psychol"},{"issue":"3","key":"zoi260117r16","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41591-022-02172-9","article-title":"A prescription for the US FDA for the regulation of health misinformation.","volume":"29","author":"Kadakia","year":"2023","journal-title":"Nat Med"},{"issue":"4","key":"zoi260117r17","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1159\/000521909","article-title":"Onychomycosis on YouTube: a cross-sectional analysis.","volume":"8","author":"Nickles","year":"2022","journal-title":"Skin Appendage Disord"},{"key":"zoi260117r18","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2023.104246","article-title":"Across the spectrum of legality: the market activities of influencers specialized in steroids and other performance and image enhancing drugs.","volume":"123","author":"Paoli","year":"2024","journal-title":"Int J Drug Policy"},{"issue":"14","key":"zoi260117r19","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1080\/10410236.2022.2149091","article-title":"What do social media influencers say about birth control? a content analysis of YouTube vlogs about birth control.","volume":"38","author":"Pfender","year":"2023","journal-title":"Health Commun"},{"issue":"1180","key":"zoi260117r20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/postmj\/qgad098","article-title":"Characteristics of Japanese physician influencers on Twitter during the COVID-19 pandemic and fact-checking their tweets on COVID-19\u2013related drugs.","volume":"100","author":"Suzuki","year":"2024","journal-title":"Postgrad Med J"},{"key":"zoi260117r21","doi-asserted-by":"publisher","DOI":"10.2196\/41867","article-title":"Communicating health literacy on prescription medications on social media: in-depth interviews with \u201cpatient influencers\u201d.","volume":"25","author":"Willis","year":"2023","journal-title":"J Med Internet Res"},{"issue":"1","key":"zoi260117r22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/08911762.2021.1913273","article-title":"The effects of message type and sponsorship disclosure in influencer marketing of prescription drugs.","volume":"35","author":"Darmawan","year":"2022","journal-title":"J Glob Mark"},{"issue":"8","key":"zoi260117r23","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1080\/02650487.2022.2054614","article-title":"Patient influencers\u2019 promotion of prescription drugs on Instagram: effects of illness disclosure on persuasion knowledge through narrative transportation.","volume":"41","author":"Kim","year":"2022","journal-title":"Int J Advert"},{"issue":"1","key":"zoi260117r24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1080\/15398285.2022.2133832","article-title":"Impact of Elon Musk\u2019s tweeting about psychiatric medication on the internet, media, and purchasing: observational study.","volume":"27","author":"Niburski","year":"2023","journal-title":"J Consum Health Internet"},{"key":"zoi260117r25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jdin.2023.05.004","article-title":"Social media dermatologic advice: dermatology without dermatologists.","volume":"12","author":"Trepanowski","year":"2023","journal-title":"JAAD Int"},{"key":"zoi260117r26","doi-asserted-by":"publisher","DOI":"10.1016\/j.copsyc.2022.101306","article-title":"Parasocial relationships, social media, & well-being.","volume":"45","author":"Hoffner","year":"2022","journal-title":"Curr Opin Psychol"},{"issue":"5","key":"zoi260117r27","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1037\/0022-3514.79.5.701","article-title":"The role of transportation in the persuasiveness of public narratives.","volume":"79","author":"Green","year":"2000","journal-title":"J Pers Soc Psychol"},{"issue":"11","key":"zoi260117r28","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1080\/1369118X.2022.2085615","article-title":"Persuasive strategies in online health misinformation: a systematic review.","volume":"26","author":"Peng","year":"2023","journal-title":"Inf Commun Soc"},{"key":"zoi260117r5","unstructured":"Dave? S, Reed? S, Woloshin? S. The FDA and FTC need to crack down on TikTok and Instagram influencers pitching prescription drugs. STAT News. January 22, 2024. Accessed September 20, 2025. https:\/\/www.statnews.com\/2024\/01\/22\/fda-ftc-tiktok-instagram-influencers-advertising-prescription-drugs\/"},{"key":"zoi260117r6","unstructured":"Sternlicht? A. TikTok\u2019s hidden \u201cOzempic economy\u201d: where weight loss influencers trade referrals for drug discounts and cash. September 19, 2023. Accessed September 20, 2025. https:\/\/fortune.com\/2023\/09\/19\/inside-ozempic-tiktok-weight-loss-influencers-hidden-economy-telehealth-cash-drug-discounts-mounjaro-glp1-wegovy\/"},{"key":"zoi260117r10","unstructured":"Untitled letter to Biohaven Pharmaceuticals regarding Nurtec ODT promotional video featuring Khlo\u00e9 Kardashian. US Food and Drug Administration. March 8, 2021. Accessed September 20, 2025. https:\/\/www.fda.gov\/media\/146528\/download"},{"key":"zoi260117r14","unstructured":"Scoping review on influencers and prescription drug marketing. Open Science Framework. Modified June 17, 2024. Accessed September 20, 2025. https:\/\/osf.io\/nydx6\/files\/osfstorage\/65f0c284e5e51c0e74bc5682"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2846840\/gell_2026_oi_260117_1773672736.19754.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T15:30:22Z","timestamp":1774279822000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2846840"}},"subtitle":["A Systematic Scoping Review"],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.2738","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]}}}